Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616317 · ClinicalTrials.gov registry record
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
A clinical trial of Antiphospholipid Syndrome, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT00616317 is a study of Antiphospholipid Syndrome that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants, below the 1,442-participant average among 6 other Antiphospholipid Syndrome trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00616317, a study of Antiphospholipid Syndrome, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Conditions Studied
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-09 |
| Est. Completion | 2040-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00616317
The ClinicalTrials.gov registry entry for NCT00616317 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,442-participant average among 6 other Antiphospholipid Syndrome trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Antiphospholipid Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00616317 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00616317 about?
NCT00616317 is a clinical study titled "Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study". The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
What is the current status of trial NCT00616317?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2006-09. Estimated completion is 2040-01.
What conditions does trial NCT00616317 study?
This clinical trial studies the following conditions: Antiphospholipid Syndrome.
Who is sponsoring clinical trial NCT00616317?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00616317 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Antiphospholipid Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Patient Registry and Biorepository
RECRUITING
-
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
RECRUITING
-
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
RECRUITING
-
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
COMPLETED · Phase 2
-
Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin
COMPLETED
-
Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.